Fetal androgen excess provides a developmental origin for polycystic ovary syndrome

References

• Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome – a hypothesis. J. Endocrinol.174, 1–5 (2002).
   PubMed Web of Science ®Google Scholar
• Abbott DH, Barnett DK, Bruns CM, Dumesic DA. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum. Reprod. Update11, 357–374 (2005).
   PubMed Web of Science ®Google Scholar
• Abbott DH, Barnett DK, Levine JE et al. Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys. Biol. Reprod.79, 154–163 (2008).
   PubMed Web of Science ®Google Scholar
• Abbott DH, Tarantal AF, Dumesic DA. Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am. J. Primatol. (2009) (In Press).
   Google Scholar
• Sullivan SD, Moenter SM. Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. Proc. Natl Acad. Sci. USA101, 7129–7134 (2004).
   PubMed Web of Science ®Google Scholar
• Foecking EM, Szabo M, Schwartz NB, Levine JE. Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator. Biol. Reprod.72, 1475–1483 (2005).
   PubMed Web of Science ®Google Scholar
• West C, Foster DL, Evans NP, Robinson J, Padmanabhan V. Intra-follicular activin availability is altered in prenatally-androgenized lambs. Mol. Cell. Endocrinol.185, 51–59 (2001).
   PubMed Web of Science ®Google Scholar
• Abbott DH, Dumesic DA, Eisner JR, Colman RJ, Kemnitz JW. Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys. Trends Endocrinol. Metab.9, 62–67 (1998).
   PubMed Web of Science ®Google Scholar
• Goverde AJ, Westerveld HE, Verhulst SM, Fauser BCJM. Polycystic ovary syndrome as a developmental disorder. Expert Rev. Obstet. Gynecol.3(6), 775–787 (2008).
   Google Scholar
• Arifin E. Shively CA, Register TC, Cline JM. Polycystic ovary syndrome with endometrial hyperplasia in a cynomolgus monkey (Macaca fascicularis). Vet. Pathol.45, 512–515 (2008).
   Google Scholar
• Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG113, 1210–1217 (2006).
   PubMed Web of Science ®Google Scholar
• Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and Type 2 diabetes mellitus. Fertil. Steril.77, 1095–1105 (2002).
   PubMed Web of Science ®Google Scholar
• Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr. Rev.24, 302–312 (2003).
   PubMed Web of Science ®Google Scholar
• Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet361, 1810–1812 (2003).
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod.19, 41–47 (2004).
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D et al.; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. DOI 10.1016/j.fertnstert.2008.06.035 (2008) (Epub ahead of print).
   Google Scholar
• Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet370, 685–697 (2007).
   PubMed Web of Science ®Google Scholar
• Dumesic DA, Abbott DH, Padmanabhan V. Polycystic ovary syndrome and its developmental origins. Rev. Endocr. Metab. Disord.8, 127–141 (2007).
   PubMed Web of Science ®Google Scholar
• Franks S. Polycystic ovary syndrome. N. Engl. J. Med.28, 853–861 (1995).
   Google Scholar
• Blank SK, McCartney CR, Marshall JC. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum. Reprod. Update12, 351–361 (2006).
   PubMed Web of Science ®Google Scholar
• Jakimiuk AJ, Weitsman SR, Navab A, Magoffin DA. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J. Clin. Endocrinol. Metab.86, 1318–1323 (2001).
   PubMed Web of Science ®Google Scholar
• Wickenheisser JK, Nelson-DeGrave VL, McAllister JM. Human ovarian theca cells in culture. Trends Endocrinol. Metab.17, 65–71 (2006).
   PubMed Web of Science ®Google Scholar
• Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J. Clin. Endocrinol. Metab.91, 2100–2104 (2006).
   PubMed Web of Science ®Google Scholar
• Urbanek M, Sam S, Legro RS, Dunaif A. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J. Clin. Endocrinol. Metab.92, 4191–4198 (2007).
   Google Scholar
• Irving-Rodgers HF, Rodgers RJ. Extracellular matrix of the developing ovarian follicle. Semin. Reprod. Med.24, 195–203 (2006).
   Google Scholar
• Pelliniemi LJ, Fröjdman K. Structural and regulatory macromolecules in sex differentiation of gonads. J. Exp. Zool.15, 523–528 (2001).
   Google Scholar
• Jiang F, Wang Z. Identification of androgen-responsive genes in the rat ventral prostate by complementary deoxyribonucleic acid subtraction and microarray. Endocrinology144, 1257–1265 (2003).
   PubMed Web of Science ®Google Scholar
• Baron D, Montfort J, Houlgatte R, Fostier A, Guiguen Y. Androgen-induced masculinization in rainbow trout results in a marked dysregulation of early gonadal gene expression profiles. BMC Genomics8, 357 (2007).
   PubMed Web of Science ®Google Scholar
• Laurich VM, Trbovich AM, O’Neill FH et al. Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17α-hydroxylase/C(17–20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation. Endocrinology143, 3351–3360 (2002).
   Google Scholar
• Derebecka-Holysz N, Lehmann TP, Holysz M, Trzeciak WH. SMAD3 inhibits SF-1-dependent activation of the CYP17 promoter in H295R cells. Mol. Cell. Biochem.307, 65–71 (2008).
   Google Scholar
• Pellatt L, Hanna L, Brincat M et al. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J. Clin. Endocrinol. Metab.92, 240–245 (2007).
   PubMed Web of Science ®Google Scholar
• Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum. Reprod. Update12, 673–683 (2006).
   PubMed Web of Science ®Google Scholar
• Cole B, Hensinger K, Maciel GA, Chang RJ, Erickson GF. Human fetal ovary development involves the spatiotemporal expression of P450c17 protein. J. Clin. Endocrinol. Metab.91, 3654–3661 (2006).
   Google Scholar
• Ellinwood WE, McClellan MC, Brenner RM, Resko JA. Estradiol synthesis by fetal monkey ovaries correlates with antral follicle formation. Biol. Reprod.28, 505–516 (1983).
   Google Scholar
• Beck-Peccoz P, Padmanabhan V, Baggiani AM et al. Maturation of hypothalamic–pituitary–gonadal function in normal human fetuses: circulating levels of gonadotropins, their common α-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone. J. Clin. Endocrinol. Metab.73, 525–532 (1991).
   PubMed Web of Science ®Google Scholar
• Rosenfield RL. Clinical review: identifying children at risk for polycystic ovary syndrome. J. Clin. Endocrinol. Metab.92, 787–796 (2007).
   PubMed Web of Science ®Google Scholar
• Barnes RB, Rosenfield RL, Ehrmann DA et al. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J. Clin. Endocrinol. Metab.79, 1328–1333 (1994).
   PubMedGoogle Scholar
• Goto M, Piper Hanley K, Marcos J et al. In humans, early cortisol biosynthesis provides mechanism to safeguard female sexual development. J. Clin. Invest.116, 953–960 (2006).
   PubMed Web of Science ®Google Scholar
• Shapiro E, Huang HY, Wu XR. Uroplakin and androgen receptor expression in the human fetal genital tract: insights into the development of the vagina. J. Urol.164, 1048–1051 (2000).
   Google Scholar
• Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Pérez-Bravo F, Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum. Reprod.17, 2573–2579 (2002).
   PubMed Web of Science ®Google Scholar
• France JT, Mason JI, Magness RR, Murry BA, Rosenfeld CR. Ovine placental aromatase: studies of activity levels, kinetic characteristics and effects of aromatase inhibitors. J. Steroid. Biochem.28, 155–160 (1987).
   Google Scholar
• Simpson ER, Zhao Y, Agarwal VR et al. Aromatase expression in health and disease. Recent Prog. Horm. Res.52, 185–213 (1997).
   PubMedGoogle Scholar
• Cresswell JL, Barker DJ, Osmond C, Egger P, Phillips DI, Fraser RB. Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet18, 1131–1135 (1997).
   Google Scholar
• Slob AK, den Hamer R, Woutersen PJ, van der Werff ten Bosch JJ. Prenatal testosterone propionate and postnatal ovarian activity in the rat. Acta Endocrinol. (Copenh.)103, 420–427 (1983).
   PubMedGoogle Scholar
• Manikkam M, Crespi EJ, Doop DD et al. Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology145, 790–798 (2004).
   PubMed Web of Science ®Google Scholar
• Laitinen J, Taponen S, Martikainen H et al. Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. Int. J. Obes. Relat. Metab. Disord.27, 710–715 (2003).
   PubMed Web of Science ®Google Scholar
• Sadrzadeh S, Klip WA, Broekmans FJ et al.; OMEGA Project group. Birth weight and age at menarche in patients with polycystic ovary syndrome or diminished ovarian reserve, in a retrospective cohort. Hum. Reprod.18, 2225–2230 (2003).
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Hitchsfeld C, Maliqueo M et al. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum. Reprod.20, 2122–2126 (2005).
   PubMed Web of Science ®Google Scholar
• Bruns CM, Baum ST, Colman RJ et al. Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys.J. Clin. Endocrinol. Metab.89, 6218–6223 (2004).
   PubMed Web of Science ®Google Scholar
• Yildiz BO, Yarali H, Oguz H, Bayraktar M. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab.88, 2031–2036 (2003).
   PubMed Web of Science ®Google Scholar
• Sam S, Coviello AD, Sung YA, Legro RS, Dunaif A. Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care31, 1237–1241 (2008).
   PubMed Web of Science ®Google Scholar
• Abbott DH, Barnett DK, Bruns CM, Dunaif A, Dumesic DA. Transient hyperglycemia in both mother and fetus from experimental induction of maternal androgen excess in a nonhuman primate model for polycystic ovary syndrome. Abstract of the 88th Annual Meeting of the Endocrine Society. Boston, MA, USA, 24–27 June 2006 (Abstract P3-113).
   Google Scholar
• Abbott DH, Goodfriend TL, Dunaif A, Muller SJ, Dumesic DA. Increased body weight and enhanced insulin sensitivity in infant female rhesus monkeys exposed to androgen excess during early gestation. Abstract of the 89th Annual Meeting of the Endocrine Society. Toronto, Canada, 2–5 June 2007 (Abstract P2-348).
   Google Scholar
• Hagenfeldt K, Janson PO, Holmdahl G et al. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum. Reprod.23, 1607–1613 (2008).
   PubMed Web of Science ®Google Scholar
• Herman RA, Jones B, Mann DR, Wallen K. Timing of prenatal androgen exposure: anatomical and endocrine effects on juvenile male and female rhesus monkeys. Horm. Behav.38, 52–66 (2000).
   PubMed Web of Science ®Google Scholar
• Steiner RA, Clifton DK, Spies HG, Resko JA. Sexual differentiation and feedback control of luteinizing hormone secretion in the rhesus monkey. Biol. Reprod.15, 206–212 (1976).
   Google Scholar
• Ellinwood WE, Baughman WL, Resko JA. The effects of gonadectomy and testosterone treatment on luteinizing hormone secretion in fetal rhesus monkeys. Endocrinology110, 183–189 (1982).
   Google Scholar
• Conley AJ, Pattison JC, Bird IM. Variations in adrenal androgen production among (nonhuman) primates. Semin. Reprod. Med.22, 311–326 (2004).
   Google Scholar
• Zhou R, Bird IM, Dumesic DA, Abbott DH. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome. J. Clin. Endocrinol. Metab.90, 6630–6637 (2005).
   Google Scholar
• Eisner JR, Dumesic DA, Kemnitz JW, Colman RJ, Abbott DH. Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation. Obes. Res.11, 279–286 (2003).
   PubMedGoogle Scholar
• Goy RW, Bercovitch FB, McBrair MC. Behavioral masculinization is independent of genital masculinization in prenatally androgenized female rhesus macaques. Horm. Behav.22, 552–571 (1988).
   PubMed Web of Science ®Google Scholar
• Hines M. Prenatal testosterone and gender-related behaviour. Eur. J. Endocrinol.155(Suppl. 1), S115–S121 (2006).
   PubMed Web of Science ®Google Scholar
• Manlove HA, Guillermo C, Gray PB. Do women with polycystic ovary syndrome (PCOS) report differences in sex-typed behavior as children and adolescents? Results of a pilot study. Ann. Hum. Biol.18, 1–12 (2008).
   Google Scholar
• Jasik CB, Lustig RH. Adolescent obesity and puberty: the “perfect storm”. Ann. NY Acad. Sci.1135, 265–279 (2008).
   PubMedGoogle Scholar
• Goy RW, Robinson JA. Prenatal exposure of rhesus monkeys to patent androgens: morphological, behavioral, and physiological consequences. Banbury Report11, 355–378 (1982).
   Google Scholar
• Zehr JL, Van Meter PE, Wallen K. Factors regulating the timing of puberty onset in female rhesus monkeys (Macaca mulatta): role of prenatal androgens, social rank, and adolescent body weight. Biol. Reprod.72, 1087–1094 (2005).
   Google Scholar
• New MI. An update of congenital adrenal hyperplasia. Ann. NY Acad. Sci.1038, 14–43 (2004).
   PubMed Web of Science ®Google Scholar
• van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years. Hum. Reprod.19, 383–392 (2004).
   PubMed Web of Science ®Google Scholar
• Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J. Clin. Endocrinol. Metab.91, 492–497 (2006).
   PubMed Web of Science ®Google Scholar
• Franks S. Polycystic ovary syndrome in adolescents. Int. J. Obes. (Lond.)32, 1035–1041 (2008).
   PubMedGoogle Scholar
• Witchel SF. Puberty and polycystic ovary syndrome. Mol. Cell. Endocrinol.25 (254–255), 146–153 (2006).
   Google Scholar
• Dumesic, DA, Schramm RD, Peterson E, Paprocki AM, Zhou R, Abbott DH. Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization. J. Clin. Endocrinol. Metab.87, 1111–1119 (2002).
   PubMed Web of Science ®Google Scholar
• Eisner JR, Dumesic DA, Kemnitz JW, Abbott DH. Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J. Clin. Endocrinol. Metab.85, 1206–1210 (2000).
   PubMed Web of Science ®Google Scholar
• Bruns CM, Baum ST, Colman RJ et al. Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome. Int. J. Obes. (Lond.)31, 1579–1585 (2007).
   PubMed Web of Science ®Google Scholar
• Zhou R, Bruns CM, Bird IM et al. Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeys. Reprod. Toxicol.23, 438–448 (2007).
   PubMed Web of Science ®Google Scholar
• Foong SC, Abbott DH, Lesnick TG, Session DR, Walker DL, Dumesic DA. Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone. Fertil. Steril.83, 1377–1383 (2005).
   PubMedGoogle Scholar
• Foong SC, Abbott DH, Zschunke MA, Lesnick TG, Phy JL, Dumesic DA. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization. J. Clin. Endocrinol. Metab.91, 2327–2333 (2006).
   PubMed Web of Science ®Google Scholar
• Cano F, García-Velasco JA, Millet A, Remohí J, Simón C, Pellicer A. Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women. J. Assist. Reprod. Genet.14, 254–261 (1997).
   PubMedGoogle Scholar
• Wood JR, Dumesic DA, Abbott DH, Strauss JF 3rd. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J. Clin. Endocrinol. Metab.92, 705–713 (2007).
   PubMed Web of Science ®Google Scholar